Cardio Archives - Page 67 of 77 - Medlatest

SORIN Q3 RESULTS SHOW GROSS MARGINS ABOVE 60%

Sorin’s profits climbed by 47.5% year on year despite sales slowdown

Boston Scientific Introduces First iPad® App for Physicians to Educate Patients About Cardiovascular Diseases and Treatments

Boston Scientific has introduced its CardioTeach™ iPad® app, an industry-first, free educational resource to help healthcare professionals better educate patients and caregivers about therapy options related to cardiovascular and peripheral diseases.

FDA Advisory Panel Makes Recommendation on Investigational Medtronic Phased RF Ablation System for Treatment of Persistent or Long-Standing Persistent Atrial Fibrillation

Medtronic has announced that the FDA Circulatory Systems Devices advisory panel has voted against the company’s Phased RF Ablation System,

FIRST PATIENT ENROLLED IN SORIN IMPLANTABLE DEFIBRILLATOR STUDY

Study will evaluate the effectiveness of PARAD+™algorithm in minimizing inappropriate defibrillator shocks

St. Jude Medical Announces FDA Clearance of First and Only Combined FFR and OCT System

Following its launch in Europe earlier this year, St Jude’s Ilumien OCT/FFR Coronary Artery Disease diagnostic tool

Why Some Patients Get Infections From Implants

Bacterial cells have gene mutations that allow them to ‘stick’ to implanted medical devices

Atricure’s Press Release confirms FDA Panel decision re: Synergy Ablation Indication

Circulatory System Devices Panel Votes in Favor of FDA Approval for AtriCure’s Surgical Ablation System to Treat Atrial Fibrillation

AtriCure Wins Panel Backing for Atrial Fibrillation Indication

An advisory panel to the FDA has voted 5-3, with one abstention, to recommend Atricure’s ablation device for patients with atrial fibrillation.

Atricure’s PMA approval for Atrial Fibrillation indication under scrutiny this week

Cardiac device maker Atricure (NASDAQ:ATRC) share price dropped on Monday after an FDA report expressed “concerns” about a clinical trial intended to support expansion of indications for one of the company’s ablation devices.

BRIC Interventional Cardiology Market to Total $4.1 Billion by 2016

BRAZILIAN, RUSSIAN, INDIAN AND CHINESE INTERVENTIONAL CARDIOLOGY MARKETS TO GROW AT 11.5 PERCENT ANNUAL AVERAGE

St. Jude 3rd quarter earnings call: Medtronic sparks Starks criticism

St Jude CEO Daniel Starks blasted rival Medtronic in 3rd quarter earnings call.

Same-day discharge for PCI patients is as safe as second-day discharge

A new study shows no significant differences in the number of deaths or readmittances to hospitals following PCI, whether the patients were discharged the same day or stayed overnight for observation.

PCI gains ground for left main and multivessel disease in new European Society of Cardiology revascularization guidelines

A new task force concludes that in certain settings Percutaneous Coronary Intervention can reasonably be considered as a treatment for both left main and three-vessel disease

Cardio